Article Details
Retrieved on: 2020-12-21 16:15:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
"The short half-life of rimegepant relative to monoclonal antibodies is especially useful for patients who have a planned or unplanned pregnancy or ...
Article found on: consumer.healthday.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here